Latha Vairavan insider trades

Open-market stock purchases and sales by Latha Vairavan, SVP Chief Financial Officer at Arcutis Biotherapeutics, Inc, from SEC Form 4 filings since May 6, 2025.

Recent trades

DateStockTradeValue
May 11, 2026ARQT Arcutis Biotherapeutics, IncSold$9.2K
May 4, 2026ARQT Arcutis Biotherapeutics, IncSold$31.7K
Mar 2, 2026ARQT Arcutis Biotherapeutics, IncSold$69.7K
Mar 2, 2026ARQT Arcutis Biotherapeutics, IncSold$2.1K
Feb 27, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Feb 27, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Feb 2, 2026ARQT Arcutis Biotherapeutics, IncSold$33.7K
Nov 3, 2025ARQT Arcutis Biotherapeutics, IncSold$2.2K

Companies traded

  • ARQT Arcutis Biotherapeutics, Inc: 7 sales, last May 11, 2026

Get free alerts when Latha Vairavan files a new trade →